ZhenGe Biotech’s $51 Million Series A Financing Round

Jones Day represented Shanghai Zhenge Biotech Co., Ltd. in the transaction. Shanghai ZhenGe Biotechnology Co.,Ltd. (“ZhenGe Biotech”) , a Chinese macromolecular pharmaceutical contract development and manufacturing…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Michael Patrini

This content is for Standard 1 Year members only.
Login Join Now